Wambeke David J.
SEC CIK 1971798 · EDGAR
BoughtSold
Most active insiders at NMTC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wambeke David J. | Chief Business Off | $737.0K | — |
| 2 | Christianson Mark | Market Development Dir | — | $54.9K |
| 3 | Mills Jason Richard | Dir | — | — |
| 4 | Mertens Steve | CTO | — | — |
| 5 | Andrle Edward | Dir | — | — |
| 6 | Rosa David A | CEO, Pres, Dir | — | — |
| 7 | MATHIESEN JEFFREY S | Dir | — | — |
| 8 | BUCKMAN PAUL | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-08 08:31 | 2026-08-27 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | Wambeke David J. | Chief Business Off | P - Purchase | $2.01 | +33.3K | 200.0K | +20% | +$67.0K |
| D | 2026-03-03 | 2026-03-01 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | Wambeke David J. | Chief Business Off | P - Purchase | $0.67 | +1.00M | 1.00M | New | +$670.0K |
| 2023-11-16 | 2023-11-16 | DMAC | DiaMedica Therapeutics Inc. | Wambeke David J. | Chief Business Off | P - Purchase | $2.46 | +20.0K | 527.1K | +4% | +$49.2K | |
| 2023-06-26 | 2023-06-23 | DMAC | DiaMedica Therapeutics Inc. | Wambeke David J. | Chief Business Off | P - Purchase | $3.91 | +38.4K | 507.1K | +8% | +$150.0K | |
| D | 2023-04-11 | 2023-04-10 | DMAC | DiaMedica Therapeutics Inc. | Wambeke David J. | Chief Business Off | P - Purchase | $1.60 | +468.8K | 468.8K | New | +$750.0K |
Purchase Sale Sale after option exercise All abbreviations